ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fracture risk"

  • Abstract Number: 1633 • 2018 ACR/ARHP Annual Meeting

    Fragility Fractures in Psoriatic Arthritis Patients: A Matched-Control Study

    Luciano Fernando Lo Giudice1, Marina Scolnik2, Florencia Pierini3, Nicolas Martin Marin Zucaro1, John Fredy Jaramillo Gallego1 and Enrique R Soriano2, 1Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Capital Federal, Argentina, 2Rheumatology Unit, Internal Medicine Service. Hospital Italiano Buenos Aires. Argentina, Buenos Aires, Argentina, 3Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, CABA, Argentina

    Background/Purpose: patients with Psoriatic Arthritis (PsA) in spite of having bone production as one of their characteristic features, very often have osteoporosis, but scarce data…
  • Abstract Number: 326 • 2017 ACR/ARHP Annual Meeting

    Osteoporosis and Vertebral Fractures Are Associated with Disease Activity, Low Vitamin D Levels and Spinal Radiographic Damage in Patients with Axial Spondyloarthritis

    Cintia Romera-López1, Cristina Fernández-Carballido2, Miguel Ángel García-Moreno3 and Teresa Pedraz4, 1Rheumatology, Hospital Universitario del Vinalopó, Elche, Spain, 2Hospital General Universitario de Elda, Elda, Spain, 3Hosppital Universitario de Elda, Elda, Spain, 4Hospital Universitario de Elda, Elda, Spain

    Background/Purpose: Osteoporosis and vertebral fractures are comorbidities of Axial Spondyloarthritis (axSpA). We evaluated the relationship between disease activity and radiographic damage and bone mineral density…
  • Abstract Number: 328 • 2017 ACR/ARHP Annual Meeting

    Secular Trends in the Risk of Fragility Fracture Among Patients with Rheumatoid Arthritis: A General Population-Based Study

    Sarah Keller1, Marcy B. Bolster2, Amar Oza3, Sharan K. Rai4, Leo Lu3, Yuqing Zhang5 and Hyon K. Choi4, 1Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2Division of Rheumatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 3Allergy, Immunology, and Rheumatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 4Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 5Department of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: The risk of osteoporotic (OP) fracture among patients with rheumatoid arthritis (RA) is higher than that of the general population. The worldwide incidence of…
  • Abstract Number: 1218 • 2017 ACR/ARHP Annual Meeting

    Caffeine Consumption and Risk of Osteoporosis: A Cross Sectional Study of 3, 210 Patients from the National Health and Nutrition Examination Survey

    Nicola Berman1, Teresa Attina2, Bruce Cronstein1, Stephen Honig1 and Michael Pillinger1, 1Rheumatology, New York University School of Medicine, Division of Rheumatology, New York, NY, 2Pediatrics, New York University School of Medicine, New York, NY

    Background/Purpose: Adenosine regulates bone metabolism. In vitro studies suggest that direct stimulation of the adenosine A2A receptor increases osteoblasts and diminishes osteoclasts, and thus inhibition…
  • Abstract Number: 1223 • 2017 ACR/ARHP Annual Meeting

    Inflammatory Bowel Diseases and the Risks of Fracture and Low Mineral Density: Review of the Literature and Meta-Analysis of Observational Cohorts

    Paulina Szafors1, Thomas Barnetche2, Cédric Lukas3, Jacques Morel4, Cécile Gaujoux-Viala5,6, Bernard Combe7 and Hélène Che8, 1Department of Rheumatology, Lapeyronie Hospital and University of Montpellier, Montpellier, France, 2Rheumatology Department, Pellegrin University Hospital, BORDEAUX, France, 3Rheumatology, CHU Lapeyronie and EA2415, Montpellier University, University of Montpellier, France, 4Rheumatology, CHU Lapeyronie and Montpellier University, Montpellier, France, 5Rheumatology, Nîmes University Hospital and EA2415 Montpellier University, Nîmes, France, 6EA 2415, Montpellier University, Nîmes, France, 7Department of rheumatology, Lapeyronie Hospital and Montpellier University, Montpellier, France, 8Rheumatology, University and Hospital Lapeyronie, University of Montpellier, France

    Background/Purpose:   Inflammatory bowel diseases (IBD), such as Crohn disease (CD) and ulcerative colitis (UC), are associated with a decreased bone mineral density caused by chronic…
  • Abstract Number: 1227 • 2017 ACR/ARHP Annual Meeting

    Osteoporosis and Breast Cancer: Can FRAX-Based Risk Factors Accurately Predict Further Fractures at This Setting?

    Salvador López-Salguero1, Laura Ranieri2, Juan Carlos Ordoñez3, Mariano Andrés4,5, Jose Ponce6 and Isabel Ibero2, 1Sección de Reumatología, Hospital General Universitario de Alicante, Alicante, Spain, 2Reumatología, Dpt. Rheumatology, Hospital General Universitario Alicante, Alicante, Spain, 3RHEUMATOLOGY, Dpt. Rheumatology, Hospital General Universitario Alicante, Alicante, Spain, 4Dpt. Rheumatology, Hospital General Universitario Alicante, Alicante, Spain, 5Universidad Miguel Hernández, Elche, Spain, 6Oncología, Dpt. Oncology, Hospital General Universitario Alicante, Alicante, Spain

    Background/Purpose: Women with breast cáncer (BC) are at risk for the development of bone loss and osteoporosis (OP) mainly due to adjuvant therapies, as aromatase…
  • Abstract Number: 2783 • 2017 ACR/ARHP Annual Meeting

    Medications Associated with Osteoporotic Fracture Risk in Patients with Rheumatoid Arthritis

    Gulsen Ozen1, Sofia Pedro2, Frederick Wolfe2 and Kaleb Michaud1, 1Rheumatology, University of Nebraska Medical Center, Omaha, NE, 2National Data Bank for Rheumatic Diseases, Wichita, KS

    Background/Purpose: Osteoporotic (OP) fractures are a major cause of disability, cost, and mortality in RA. Besides increased OP fracture risk, chronic inflammation and pain predispose…
  • Abstract Number: 338 • 2016 ACR/ARHP Annual Meeting

    Abaloparatide-SC Significantly Reduces Vertebral and Nonvertebral Fractures and Increases Bone Mineral Density (BMD) Regardless of Age, BMD T-Score, or Prior Fracture at Baseline

    F Cosman1, Gary Hattersley2, PD Miller3, Ming-Yu Hu4, Luis Augusto Tavares Russo5, Bente Riis6, Greg Williams7 and Lorraine Fitzpatrick8, 1Clinical Research Center, Helen Hayes Hospital, West Haverstraw, NY, 2Research, Radius Health, Inc., Waltham, MA, 3Colorado Center for Bone Research, Lakewood, CO, 4Biometrics, Radius Health, Inc., Waltham, MA, 5CCBR Brasil, Rua Mena Barreto, 33 Botofogo, 22271, Rio de Janeiro, Brazil, 6Nordic Biosciences A/S, 2730 Herlev, Denmark, 7Clinical Development, Radius Health, Inc., Waltham, MA, 8Chief Medical Officer, Radius Health, Inc., Waltham, MA

    Background/Purpose:  Abaloparatide is a novel 34 amino acid peptide created to be a potent and selective activator of the PTH 1 receptor signaling pathway and…
  • Abstract Number: 344 • 2016 ACR/ARHP Annual Meeting

    Is Rheumatoid Arthritis a Risk Factor for Fractures: A Systematic Review of Observational Studies

    Ambika Gupta1, Stephanie Pipe2, Tanveer Towheed3 and Tassos Anastassiades2, 1Internal Medicine, Queen's University, Kingston, ON, Canada, 2Queen's University, Kingston, ON, Canada, 3Dept of Medicine, Queen's University, Kingston, ON, Canada

    Background/Purpose: Rheumatoid Arthritis (RA) is a known risk factor for osteoporosis. There are many factors that contribute to this increased risk, including the use of…
  • Abstract Number: 355 • 2016 ACR/ARHP Annual Meeting

    Fracture Incidence Rates in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis

    Raveendhara R. Bannuru1, Elizaveta Vaysbrot2, Mikala Osani2, Lenore Buckley3, Howard Fink4 and Timothy E. McAlindon5, 1Rheumatology, Tufts Med Ctr, Boston, MA, 2Rheumatology, Tufts Medical Center, Boston, MA, 3Rheumatology, Yale University, North Haven, CT, 4Minneapolis VA Health Care System, Washington, DC, 5Division of Rheumatology, Tufts Medical Center, Boston, MA

    Background/Purpose: Transplants increase risk of bone loss and fractures and reduce quality of life. Information on fracture incidence is important when making clinical decisions about…
  • Abstract Number: 356 • 2016 ACR/ARHP Annual Meeting

    Osteoporotic Fracture As the Main Risk Factor in the Detection of Osteoporosis in Men Under 70 Years

    JUAN MARIA BLANCO MADRIGAL1,2, MARIA LUZ GARCIA VIVAR3, Eva Galindez-Agirregoikoa3, OLAIA BEGOÑA FERNANDEZ BERRIZBEITIA4, Itziar Calvo Zorrilla3, Edurne Guerrero Basterretxea3, Esther Ruíz Lucea5, Ignacio Torre Salaberri6, Lidia Estopiñán-Fortea3, Catalina Gómez Arango7 and Amaia Bilbao-González8, 1Rheumatology Department, Basurto University Hospital, VITORIA, Spain, 2Rheumatology, Rheumatology Department, Basurto University Hospital, VITORIA, Spain, 3Rheumatology Department, Basurto University Hospital, Bilbao, Spain, 4Rheumatology Department, Basurto University Hospital, BILBAO, Spain, 5Rheumatology Department, Basurto University Hospital., Bilbao, Spain, 6Rheumatology, Hospital Universitario de Basurto. Bilbao., Bilbao, Spain, 7Rheumatology, Rheumatology Department, Basurto University Hospital, Bilbao, Spain, 8Research Department, Basurto University Hospital, Bilbao, Spain

    Background/Purpose: Osteoporosis (OP) in males under 70 years is less common than postmenopausal and senile, but generates significant social and health costs associated with morbidity…
  • Abstract Number: 1181 • 2016 ACR/ARHP Annual Meeting

    Risk Factors for Incident Fractures in Patients with Systemic Lupus Erythematosus on Dialysis

    Brian Le1,2, Jennifer Waller3, Reshmitha Radhakrishnan4, Sun Jung Oh4, Monique Bethel2,5, Christopher Rice4 and Laura Carbone2,6, 1Department of Internal Medicine, Augusta University, Augusta, GA, 2Specialty Care, Charlie Norwood VA Medical Center, Augusta, GA, 3Biostatistics, Augusta University, Augusta, GA, 4School of Medicine, Augusta University, Augusta, GA, 51120 15th Street, BI 5070, Augusta University, Augusta, GA, 6Rheumatology, Augusta University, Augusta, GA

    Background/Purpose:  Osteoporosis and osteoporotic fractures are significant comorbidities in patients with systemic lupus erythematosus (SLE). Hip fractures are being increasingly recognized as a complication of…
  • Abstract Number: 1232 • 2016 ACR/ARHP Annual Meeting

    Interdisciplinary Osteoporosis Clinical Working Group and Fracture Liaison Service at Loma Linda University Medical Center (LLUMC): Laying the Groundwork

    Karina Marianne D. Torralba1, Micah Yu2, Cong-Bin Wang3, Kevin A. Codorniz4, James P. Larsen3, Silvana M Giannelli5, Vaneet Sandhu6, Nasim Daoud7 and Gary D. Botimer3, 1Rheumatology, Loma Linda University, Loma Linda, CA, 2Internal Medicine, Loma Linda University Medical Center, Loma Linda, CA, 3Loma Linda University Medical Center, Loma Linda, CA, 4Loma Linda University University Medical Center, Loma Linda, CA, 5Division of Endocrinology, Loma Linda University, Loma Linda, CA, 6Division of Rheumatology, Loma Linda University, Loma Linda, CA, 7Division of Rheumatology, Loma Linda University Medical Center, Loma Linda, CA

    Background/Purpose:  There is an ongoing effort worldwide to effect quality improvement to address secondary prevention of fractures. Patients who have incurred fractures attributed to osteoporosis…
  • Abstract Number: 1705 • 2016 ACR/ARHP Annual Meeting

    The Risk of Fracture Among Patients with Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis

    Lauren Harter1, Daniel Shin2, Joshua F. Baker3, Junko Takeshita2, Thorvardur Love4,5, Joel Gelfand6 and Alexis Ogdie7, 1Medicine, University of Pittsburgh, Pittsburgh, PA, 2University of Pennsylvania, Philadelphia, PA, 3Rheumatology, University of Pennsylvania, Philadelphia, PA, 4Faculty of Medicine, University of Iceland, Reykjavik, Iceland, 5Landspitali University Hospital, Reykjavík, Iceland, 6University of Pennsylvania Health System , Philadelphia, PA, 7Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA

    Background/Purpose: While rheumatoid arthritis (RA) has been linked to an increased incidence of osteoporosis (OP) and fracture, few studies have examined the risk of fracture…
  • Abstract Number: 2541 • 2016 ACR/ARHP Annual Meeting

    Glucocorticoid Use and Low Thoracic Bone Mineral Density Are Predictors for Clinical Fractures in Patients with Rheumatoid Arthritis: Five-Year Findings of the Tomorrow Study

    Kenji Mamoto1, Kentaro Inui2, Tadashi Okano1, Yuko Sugioka3, Masahiro Tada4, Tatsuya Koike5 and Hiroaki Nakamura6, 1Orthopedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan, 2Rheumatology & Orthopaedics, Higashisumiyoshi Morimoto Hospital, Osaka, Japan, 3o, Osaka, Japan, 4Orthopedic Surgery, Osaka City General Hospital, Osaka, Japan, 5Center for Senile Degenerative Disorders (CSDD), Osaka City University Graduate School of Medicine, Osaka, Japan, 6Orthopaedic Surgery, Osaka City University Medical School, Osaka, Japan

    Background/Purpose: Patients with rheumatoid arthritis (RA) who have muscle weakness and stiff or painful joints might be at increased risk of falls and fractures. The…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology